The Cochrane Library: Cochrane Database of Systematic Reviews

Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

DOI: 10.1002/14651858

Browse by Topic

  1. Acute Respiratory Infections (195)
  2. Airways (378)
  3. Anaesthesia (283)
  4. Back (89)
  5. Bone, Joint and Muscle Trauma (249)
  6. Breast Cancer (80)
  7. Childhood Cancer (47)
  8. Colorectal Cancer (258)
  9. Consumers and Communication (98)
  10. Cystic Fibrosis and Genetic Disorders (153)
  11. Dementia and Cognitive Improvement (256)
  12. Depression, Anxiety and Neurosis (716)
  13. Developmental, Psychosocial and Learning Problems (168)
  14. Drugs and Alcohol (96)
  15. Ear, Nose and Throat Disorders (134)
  16. Effective Practice and Organisation of Care (129)
  17. Epilepsy (88)
  18. Eyes and Vision (185)
  19. Fertility Regulation (96)
  20. Gynaecological Cancer (170)
  21. Haematological Malignancies (130)
  22. Heart (196)
  23. Hepato-Biliary (375)
  24. HIV/AIDS (152)
  25. Hypertension (128)
  26. Incontinence (154)
  27. Infectious Diseases (154)
  28. Inflammatory Bowel Disease and Functional Bowel Disorders (113)
  29. Injuries (195)
  30. Lung Cancer (40)
  31. Menstrual Disorders and Subfertility (241)
    1. CLIMACTERIC/MENOPAUSE (18)
    2. DISORDERS OF MENSTRUAL CYCLING / OLIGO-AMENORRHOEA IN ASSOCIATION WITH: (13)
    3. EVALUATION OF DIAGNOSTIC TECHNIQUES IN THE INVESTIGATION OR ASSESSMENT OF THE SUBFERTILE COUPLE (4)
    4. EVALUATION OF MEASURES AIMED AT THE PREVENTION OF SUBFERTILITY (0)
    5. EVALUATION OF SUBFERTILITY TREATMENTS RELATING TO THE FEMALE PARTNER (113)
      1. ASSISTED CONCEPTION TECHNIQUES (50)
        1. Procedures (non-surgical) (48)
          1. Culture media or oocytes and/or embryos (12)
          2. Embryo cryopreservation (2)
          3. Endometrial preparation (5)
          4. Luteal support (hCG; progesterone) (2)
          5. Ovarian stimulation protocols (drug regimes and modalities) (18)
            1. Coasting (withholding gonadotrophins) for preventing ovarian hyperstimulation syndromeReview
            2. Depot versus daily administration of gonadotrophin-releasing hormone agonist protocols for pituitary down regulation in assisted reproduction cyclesReview
            3. Embryo freezing for preventing ovarian hyperstimulation syndromeReview
            4. Follicle-stimulating hormone and human menopausal gonadotropin for ovarian stimulation in assisted reproduction cyclesWithdrawnReview
            5. FSH replaced by low-dose hCG in the late follicular phase versus continued FSH for assisted reproductive techniquesReview
            6. Glucocorticoid supplementation during ovarian stimulation for IVF or ICSIProtocol
            7. Gonadotrophin-releasing hormone antagonists for assisted reproductive technologyReview
            8. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cyclesReview
            9. Human chorionic gonadotrophin priming for fertility treatment with in vitro maturationProtocol
            10. Human menopausal gonadotropin versus recombinant follicle stimulation hormone for ovarian stimulation in assisted reproductive cyclesWithdrawnReview
            11. Intra-venous fluids for the prevention of severe ovarian hyperstimulation syndromeReview
            12. Long-acting FSH versus daily FSH for women undergoing assisted reproductionReview
            13. Monitoring of stimulated cycles in assisted reproduction (IVF and ICSI)Review
            14. Oral contraceptive pill, progestogen or estrogen pre-treatment for ovarian stimulation protocols for women undergoing assisted reproductive techniquesReview
            15. Recombinant Luteinizing Hormone (rLH) for controlled ovarian hyperstimulation in assisted reproductive cyclesReview
            16. Recombinant versus urinary follicle stimulating hormone for ovarian stimulation in assisted reproduction cyclesWithdrawnReview
            17. Recombinant versus urinary gonadotrophin for ovarian stimulation in assisted reproductive technology cyclesReview
            18. Recombinant versus urinary human chorionic gonadotrophin for final oocyte maturation triggering in IVF and ICSI cyclesReview
          6. Technique modalities (IVF, GIFT, ZIFT) (9)
        2. Surgery (2)
      2. ECTOPIC PREGNANCY (2)
      3. INFERTILITY ASSOCIATED WITH POLYCYSTIC OVARY SYNDROME (12)
      4. INFERTILITY TREATMENT FOR PREMATURE OVARIAN FAILURE (0)
      5. MECHANICAL INFERTILITY (TUBAL BLOCKAGE, PELVIC ADHESIONS) (10)
      6. OLIGO/ANOVULATION. OVULATION INDUCTION BY MEANS OF (5)
      7. OTHER (13)
      8. SPERM-MUCUS INTERACTION IMPAIRMENT; \"CERVICAL\" INFERTILITY (1)
      9. SUBFERTILITY ASSOCIATED WITH ENDOMETRIOSIS (4)
      10. SUBFERTILITY ASSOCIATED WITH FIBROIDS (1)
      11. UNEXPLAINED SUBFERTILITY (15)
    6. EVALUATION OF SUBFERTILITY TREATMENTS RELATING TO THE MALE PARTNER (14)
    7. EXCESSIVE MENSTRUAL BLEEDING (25)
    8. GYNAECOLOGICAL SURGERY (excluding malignant conditions but including complications after surgery) (14)
    9. HIRSUTISM AND RELATED ACNE (4)
    10. PELVIC PAIN (30)
    11. PREMATURE OVARIAN FAILURE (0)
    12. PREMENSTRUAL SYNDROME (includes cyclical mood swings and premenstrual exacerbation of symptoms) (6)
  32. Metabolic and Endocrine Disorders (139)
  33. Methodology Review (34)
  34. Movement Disorders (98)
  35. Multiple Sclerosis and Rare Diseases of the Central Nervous System (53)
  36. Musculoskeletal (297)
  37. Neonatal (372)
  38. Neuromuscular Disease (239)
  39. Occupational Safety and Health (121)
  40. Oral Health (208)
  41. Pain, Palliative and Supportive Care (289)
  42. Peripheral Vascular Diseases (390)
  43. Pregnancy and Childbirth (650)
  44. Prostatic Diseases and Urologic Cancers (71)
  45. Public Health (30)
  46. Renal (223)
  47. Schizophrenia (245)
  48. Sexually Transmitted Infections (12)
  49. Sexually Transmitted Infections (16)
  50. Skin (277)
  51. Stroke (217)
  52. Tobacco Addiction (84)
  53. Upper Gastrointestinal and Pancreatic Diseases (192)
  54. Wounds (183)

SEARCH